Status:
UNKNOWN
Exercise Fatigue Parameters and Endothelial Function in Pediatric Patients With a History of COVID-19 Infection or MIS-C
Lead Sponsor:
Rambam Health Care Campus
Collaborating Sponsors:
The Baruch Padeh Medical Center, Poriya
Conditions:
COVID-19
MIS-C Associated With COVID-19
Eligibility:
All Genders
5+ years
Phase:
NA
Brief Summary
Acute coronavirus disease 2019 (COVID-19) infection can include cardiac and pulmonary manifestations as well as post-infectious complications such as multisystem inflammatory syndrome (MIS-C), also kn...
Detailed Description
Introduction: coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 is currently a major public health challenge. COVID-19 infection results in diverse...
Eligibility Criteria
Inclusion
- Patients aged 5 years and older recovering from COVID-19 infection.
- For EndoPAT assessment-at least 3 months since the patient was diagnosed with COVID -19 infection or with PIMS
Exclusion
- Cardiac or pulmonary comorbidity other than COVID-19 related morbidity.
- Inability to perform all study assessments. If a patient will be able to complete one of the assessments or more, the data will be collected and included in the analysis.
- Intercurrent systemic conditions or illness and/or medication use that could affect cardiopulmonary exercise capacity or EndoPAT™.
Key Trial Info
Start Date :
November 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05205642
Start Date
November 1 2021
End Date
June 30 2024
Last Update
January 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rambam Medical Center
Haifa, Israel